Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $473

Benzinga · 1d ago
Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $492 to $473.